drugset

drugset / Trial / NCT00306319

Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia

NCT00306319 ↗

Phase 2 Completed 23 enrolled Radboud University Medical Center

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Pharmacokinetic study in TB patients to determine the effect of rifampicin on the pharmacokinetic profile of moxifloxacin.

Timeline

Start: 2006-01
Primary completion: 2006-05
Completion: 2006-05

Publications

Results Nijland HM, Ruslami R, Suroto AJ, Burger DM, Alisjahbana B, van Crevel R, Aarnoutse RE. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis. Clin Infect Dis. 2007 Oct 15;45(8):1001-7. doi: 10.1086/521894. Epub 2007 Sep 4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Moxifloxacin	Small molecule	400 mg	—

Indications